Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kenya
Kenya: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 87.0% in 2025. ▲ Rising
Latest (2025)
87.0%
Change on year
down 2.2%
World rank
86th
of 194 countries
All-time high
94.0%
in 2021
All-time low
0.0%
in 2008
Years of data
18
2008–2025
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kenya, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Kenya is 87.0%, measured in 2025.
Compared with earlier readings it is down 2.2% on the previous year and up 8.8% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Kenya peaked at 94.0% in 2021 and was at its lowest, 0.0%, in 2008.
That places Kenya 86th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 18 years of available data.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Kenya, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 85.0% | — |
| 2012 | 82.0% | -3.5% |
| 2013 | 77.0% | -6.1% |
| 2014 | 84.0% | +9.1% |
| 2015 | 80.0% | -4.8% |
| 2016 | 83.0% | +3.8% |
| 2017 | 78.0% | -6.0% |
| 2018 | 89.0% | +14.1% |
| 2019 | 93.0% | +4.5% |
| 2020 | 92.0% | -1.1% |
| 2021 | 94.0% | +2.2% |
| 2022 | 93.0% | -1.1% |
| 2023 | 91.0% | -2.2% |
| 2024 | 89.0% | -2.2% |
| 2025 | 87.0% | -2.2% |
Kenya compared with similar countries
- Kenya's 87.0% is above the median for lower middle income countries, which is 84.0%, 1.0× the median. (47 countries reporting)
- Kenya's 87.0% is above the median for Sub-Saharan Africa, which is 82.5%, 1.1× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 75.1% | 0.0% | 93.0% | 10 |
| 2020s | 91.0% | 87.0% | 94.0% | 6 |
Countries ranked near Kenya
- 86 Kiribati 87.0% compare
- 86 Dominican Republic 87.0% compare
- 86 Netherlands 87.0% compare
- 86 Niger 87.0% compare
- 86 Lithuania 87.0% compare
More health data for Kenya
- Un projection of annual infant deaths, annual growth rate -1.44 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.6026 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,119 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,059 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0621 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.28 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Kenya?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Kenya was 87.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Kenya?
- The highest recorded value was 94.0% in 2021.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Kenya?
- The lowest recorded value was 0.0% in 2008.
- How does Kenya rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Kenya ranks 86th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Kenya?
- Over the last ten years it is up 8.8%. The long-run trend across the full record is rising.
- Where does this Kenya data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).